Yearbooks

  • Clinical Trials Arena proudly publishes a collection of yearbooks analyzing the key issues from the previous year. These free-to-read online publications are filled with case study focused contributions from leading voices from specific industries. Content from the Yearbooks is developed alongside our research for our world-renowned conferences and the publications bring together case studies, knowledge and expertise from senior-level executives from companies large and small from the sector. Each publication is backed by a focused marketing campaign to ensure a relevant and senior-level global readership. Each yearbook can be accessed throughout the year for your day to day reference.


    4th Edition Top

    4th Edition

    2016 has proved an eventful year on the international scene and one that will no doubt spark changes to the world of clinical trials. With the announcements of Brexit and a new US president, many in the industry are rightly seeking guidance for what changes 2017 could bring for professionals working within the industry. Beyond political changes, trial sponsors will also have to adapt to operational changes in the wake of new EU regulations. Despite this, the pillars of successful trials still remain rooted in good working relationships and strong communication channels.

    The 4th edition of the Clinical Trial Yearbook serves as an accessible reference point for this rapidly evolving industry.


    3rd Edition Top

    3rd Edition

    With clinical trials proving more complex and budgets becoming tighter, it has never been more important for the industry to come together and collaborate on how best to optimize their clinical operations and supply processes.

    This unique publication, with content provided by industry leaders from companies big and small, provides a fantastic platform for exploring effective strategies in outsourcing, data management and clinical operations; encourages readers to consider how these concepts can be introduced into their own company processes.


    2nd Edition Top

    2nd Edition

    According to a recent survey of biopharmaceutical outsourcing professionals, the main reason that partnerships fail is because they were not fit for purpose when set up. There are numerous well-documented cases where the value sought from a partnership was never fully realized, rendering the partnership unsustainable. All this begs the question: how does one go about designing a suitable commercial, legal and governance structure to support the deal that an organization needs? The first step is to investigate those needs.



    1st Edition Top

    1st Edition

    To say that it's been a challenging year for clinical trials and the biopharma industry would be an understatement; the continuous struggle for biotechs to obtain funding, diminishing R&D pipeline for big pharma, increasing trend of mergers and acquisitions across the sector, and globally decreasing budgets have caused huge strategic pressures. This, coupled with the ever increasing regulatory scrutiny on clinical practices, enhancing expectations for proactive operational quality, continuously reducing access to patients globally and increasing pressure from competition, means that there is plenty to ensure that the industry stay on their toes! The positive thing about these pressures is that they keep the sector looking and moving forward, searching for new and more efficient ways to achieve goals.